Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism.
BACKGROUND: The psychotomimetic effects of N-methyl-D-aspartate (NMDA) receptor antagonists in healthy humans and their tendency to aggravate psychotic symptoms in schizophrenic patients have promoted the notion of altered glutamatergic neurotransmission in the pathogenesis of schizophrenia. METHODS...
Main Authors: | Just Genius, Johanna Geiger, Anna-Lena Dölzer, Jens Benninghoff, Ina Giegling, Annette M Hartmann, Hans-Jürgen Möller, Dan Rujescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3711936?pdf=render |
Similar Items
-
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.
by: Pilar eSánchez-Blázquez, et al.
Published: (2014-01-01) -
Memantine protects thalamocortical hyper‐glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc−
by: Motohiro Okada, et al.
Published: (2019-02-01) -
Creatine protects against excitoxicity in an in vitro model of neurodegeneration.
by: Just Genius, et al.
Published: (2012-01-01) -
Léčivy navozené dysbalance draslíku
by: Gregorová, Kateřina
Published: (2011) -
Svalová dysbalance u hráčů házené
by: Pokorný, Jakub
Published: (2007)